

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48212725 |
| 2 | mitotic chromosome condensation (GO:0007076) | 4.36124699 |
| 3 | leukocyte aggregation (GO:0070486) | 3.76189846 |
| 4 | histone H3-K36 demethylation (GO:0070544) | 3.69892005 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59442705 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.59442705 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59442705 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59442705 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59442705 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.59442705 |
| 11 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.59198644 |
| 12 | regulation of RNA export from nucleus (GO:0046831) | 3.58913381 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46302959 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39215223 |
| 15 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.37717321 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37662395 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37662395 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37036566 |
| 19 | tolerance induction (GO:0002507) | 3.32776504 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32344330 |
| 21 | negative regulation of histone methylation (GO:0031061) | 3.31949498 |
| 22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20984235 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18674451 |
| 24 | heterochromatin organization (GO:0070828) | 3.13634094 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.12092963 |
| 26 | regulation of histone H3-K27 methylation (GO:0061085) | 3.08936767 |
| 27 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08910350 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.04434859 |
| 29 | chromosome condensation (GO:0030261) | 3.04352894 |
| 30 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.02075634 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01689244 |
| 32 | DNA unwinding involved in DNA replication (GO:0006268) | 3.00273310 |
| 33 | negative T cell selection (GO:0043383) | 3.00209366 |
| 34 | regulation of podosome assembly (GO:0071801) | 2.99538060 |
| 35 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96954930 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 2.91962238 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 2.91769128 |
| 38 | response to peptidoglycan (GO:0032494) | 2.91669838 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 2.90862613 |
| 40 | positive regulation of isotype switching (GO:0045830) | 2.89640835 |
| 41 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.88090675 |
| 42 | nuclear pore complex assembly (GO:0051292) | 2.85190025 |
| 43 | pre-miRNA processing (GO:0031054) | 2.85006089 |
| 44 | myeloid dendritic cell activation (GO:0001773) | 2.82810714 |
| 45 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.82435052 |
| 46 | modulation by symbiont of host cellular process (GO:0044068) | 2.81484050 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 2.80676744 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.80460609 |
| 49 | response to muramyl dipeptide (GO:0032495) | 2.79248363 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 2.77224046 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 2.74210762 |
| 52 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.73955142 |
| 53 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72986715 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 2.72133661 |
| 55 | DNA packaging (GO:0006323) | 2.72103451 |
| 56 | modulation by virus of host process (GO:0019054) | 2.72038961 |
| 57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.72032594 |
| 58 | positive thymic T cell selection (GO:0045059) | 2.71920182 |
| 59 | cellular response to virus (GO:0098586) | 2.71698263 |
| 60 | T cell migration (GO:0072678) | 2.71167216 |
| 61 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70949620 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.69911046 |
| 63 | positive regulation of B cell mediated immunity (GO:0002714) | 2.67746327 |
| 64 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.67746327 |
| 65 | mitotic sister chromatid segregation (GO:0000070) | 2.65890078 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.65662226 |
| 67 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.65530617 |
| 68 | regulation of histone H3-K9 methylation (GO:0051570) | 2.65391628 |
| 69 | histone lysine demethylation (GO:0070076) | 2.64804163 |
| 70 | mitotic sister chromatid cohesion (GO:0007064) | 2.61480571 |
| 71 | regulation of B cell differentiation (GO:0045577) | 2.59140744 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.58318966 |
| 73 | B cell mediated immunity (GO:0019724) | 2.58303013 |
| 74 | protein localization to kinetochore (GO:0034501) | 2.57599690 |
| 75 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.57331630 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57192090 |
| 77 | T cell apoptotic process (GO:0070231) | 2.57097174 |
| 78 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.56812600 |
| 79 | response to type I interferon (GO:0034340) | 2.56214347 |
| 80 | histone demethylation (GO:0016577) | 2.56072233 |
| 81 | regulation of chromatin binding (GO:0035561) | 2.55954462 |
| 82 | histone H4-K16 acetylation (GO:0043984) | 2.55720396 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.54993633 |
| 84 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.53907500 |
| 85 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.53733510 |
| 86 | nuclear pore organization (GO:0006999) | 2.53729057 |
| 87 | nuclear envelope disassembly (GO:0051081) | 2.53260054 |
| 88 | membrane disassembly (GO:0030397) | 2.53260054 |
| 89 | sister chromatid segregation (GO:0000819) | 2.50915415 |
| 90 | cellular response to type I interferon (GO:0071357) | 2.50811476 |
| 91 | type I interferon signaling pathway (GO:0060337) | 2.50811476 |
| 92 | trophectodermal cell differentiation (GO:0001829) | 2.50335241 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50231535 |
| 94 | T cell homeostasis (GO:0043029) | 2.49649102 |
| 95 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.49411225 |
| 96 | defense response to protozoan (GO:0042832) | 2.48907608 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.47202047 |
| 98 | embryonic process involved in female pregnancy (GO:0060136) | 2.46935997 |
| 99 | regulation of vitamin metabolic process (GO:0030656) | 2.46929467 |
| 100 | histone H3-K4 methylation (GO:0051568) | 2.46664277 |
| 101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45649648 |
| 102 | response to host (GO:0075136) | 2.45649648 |
| 103 | response to host defenses (GO:0052200) | 2.45649648 |
| 104 | positive regulation of humoral immune response (GO:0002922) | 2.45379266 |
| 105 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.44638191 |
| 106 | histone H3-K9 demethylation (GO:0033169) | 2.44220503 |
| 107 | trophoblast giant cell differentiation (GO:0060707) | 2.44169099 |
| 108 | response to interleukin-15 (GO:0070672) | 2.44069098 |
| 109 | regulation of RNA stability (GO:0043487) | 2.43804264 |
| 110 | Peyers patch development (GO:0048541) | 2.43547104 |
| 111 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.43547104 |
| 112 | response to protozoan (GO:0001562) | 2.42986085 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42341912 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42178316 |
| 115 | response to host immune response (GO:0052572) | 2.42178316 |
| 116 | regulation of histone methylation (GO:0031060) | 2.41636342 |
| 117 | pinocytosis (GO:0006907) | 2.38786980 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.38237021 |
| 119 | natural killer cell mediated immunity (GO:0002228) | 2.38061810 |
| 120 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.38061810 |
| 121 | respiratory burst (GO:0045730) | 2.37448963 |
| 122 | histone mRNA catabolic process (GO:0071044) | 2.36629183 |
| 123 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.36619339 |
| 124 | mRNA stabilization (GO:0048255) | 2.36538118 |
| 125 | RNA stabilization (GO:0043489) | 2.36538118 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.36533600 |
| 127 | negative regulation of cell killing (GO:0031342) | 2.36533600 |
| 128 | histone H3-K4 trimethylation (GO:0080182) | 2.36173669 |
| 129 | DNA topological change (GO:0006265) | 2.36099331 |
| 130 | protein localization to chromosome, centromeric region (GO:0071459) | 2.35520189 |
| 131 | T cell lineage commitment (GO:0002360) | 2.34923722 |
| 132 | thymic T cell selection (GO:0045061) | 2.34625302 |
| 133 | positive regulation of DNA recombination (GO:0045911) | 2.34051035 |
| 134 | germinal center formation (GO:0002467) | 2.33733432 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33232565 |
| 136 | kinetochore organization (GO:0051383) | 2.32864801 |
| 137 | granulocyte activation (GO:0036230) | 2.32044220 |
| 138 | pore complex assembly (GO:0046931) | 2.31955298 |
| 139 | N-terminal protein amino acid acetylation (GO:0006474) | 2.31543930 |
| 140 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.31272938 |
| 141 | leukocyte cell-cell adhesion (GO:0007159) | 2.31007856 |
| 142 | lymphocyte homeostasis (GO:0002260) | 2.30964830 |
| 143 | negative regulation of B cell proliferation (GO:0030889) | 2.29047174 |
| 144 | mitotic nuclear envelope disassembly (GO:0007077) | 2.28244564 |
| 145 | neutrophil activation (GO:0042119) | 2.28182072 |
| 146 | DNA strand elongation (GO:0022616) | 2.27917611 |
| 147 | histone H4-K5 acetylation (GO:0043981) | 2.27622883 |
| 148 | histone H4-K8 acetylation (GO:0043982) | 2.27622883 |
| 149 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.26928054 |
| 150 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.26834588 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.25721537 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.25268919 |
| 153 | positive regulation of macrophage differentiation (GO:0045651) | 2.24521389 |
| 154 | positive regulation of T cell cytokine production (GO:0002726) | 2.24173228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.13582439 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.00825291 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.93817824 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.92069129 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.86011293 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31034314 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26982698 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.02145689 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00137527 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.82021936 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75794804 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64846442 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63030632 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52229683 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35333739 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.33801380 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33564022 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33182372 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27016756 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24165314 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.23311579 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.22870395 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21374980 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16760837 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15560781 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13070306 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.05181595 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04489140 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.99184719 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92411659 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85061382 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79651440 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.78679892 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.76099661 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74457752 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73310839 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.72422500 |
| 38 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.71940200 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68979361 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67446553 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65314781 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63644873 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60966581 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60040938 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54776924 |
| 46 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.51624265 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50094138 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46504566 |
| 49 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41615661 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41153759 |
| 51 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.40343286 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39020594 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37453554 |
| 54 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36574837 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33494123 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31828734 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.31813945 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31208950 |
| 59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.31030060 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.31030060 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.31030060 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29041726 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28877379 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27625259 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26275239 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23082291 |
| 67 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.21394303 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21116415 |
| 69 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21110170 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20341423 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.19725105 |
| 72 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19383050 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17852061 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17088893 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17011224 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16069618 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15730271 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15249218 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14671490 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13977068 |
| 81 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.13545792 |
| 82 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12553009 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12007107 |
| 84 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11387137 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10585862 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10449493 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09859827 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09207083 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08826135 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06936661 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06716709 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06450699 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06426961 |
| 94 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06140914 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04183716 |
| 96 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03528059 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02570981 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00831525 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00203590 |
| 100 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99574684 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99087952 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97578967 |
| 103 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96999306 |
| 104 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.95974391 |
| 105 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95879179 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95016768 |
| 107 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94297360 |
| 108 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93346467 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93280864 |
| 110 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92325250 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91348939 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90069830 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88295206 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87097277 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87045717 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85518640 |
| 117 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.83690655 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83672489 |
| 119 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81521301 |
| 120 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.81408015 |
| 121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81396615 |
| 122 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.80655526 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80267032 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79042469 |
| 125 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.78821682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.11644652 |
| 2 | MP0005451_abnormal_body_composition | 3.05935518 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.94843077 |
| 4 | MP0003303_peritoneal_inflammation | 2.82036688 |
| 5 | MP0005671_abnormal_response_to | 2.72605781 |
| 6 | MP0009785_altered_susceptibility_to | 2.72203486 |
| 7 | MP0000685_abnormal_immune_system | 2.71544750 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.46250362 |
| 9 | MP0001800_abnormal_humoral_immune | 2.45761634 |
| 10 | MP0001790_abnormal_immune_system | 2.44774002 |
| 11 | MP0005387_immune_system_phenotype | 2.44774002 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.38395147 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.36705888 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.29589295 |
| 15 | MP0005025_abnormal_response_to | 2.26191777 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.23091119 |
| 17 | MP0002723_abnormal_immune_serum | 2.19873793 |
| 18 | MP0008057_abnormal_DNA_replication | 2.16110828 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.15895797 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.15731900 |
| 21 | MP0002398_abnormal_bone_marrow | 2.13047149 |
| 22 | MP0002419_abnormal_innate_immunity | 2.12036175 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.10839742 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.10452942 |
| 25 | MP0001819_abnormal_immune_cell | 2.10278672 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 2.07219333 |
| 27 | MP0002405_respiratory_system_inflammati | 2.07168848 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 2.06454369 |
| 29 | MP0009278_abnormal_bone_marrow | 2.06338574 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.02425469 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.94622871 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.93998137 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.85738605 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.85738605 |
| 35 | MP0000490_abnormal_crypts_of | 1.82521990 |
| 36 | MP0000716_abnormal_immune_system | 1.81590534 |
| 37 | MP0003077_abnormal_cell_cycle | 1.78458937 |
| 38 | MP0002722_abnormal_immune_system | 1.77133640 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.76269761 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.72578895 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.69560633 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.68578503 |
| 43 | MP0001853_heart_inflammation | 1.67547530 |
| 44 | MP0004264_abnormal_extraembryonic_tissu | 1.66745883 |
| 45 | MP0006082_CNS_inflammation | 1.65785530 |
| 46 | MP0004947_skin_inflammation | 1.63171491 |
| 47 | MP0002429_abnormal_blood_cell | 1.62996795 |
| 48 | MP0003724_increased_susceptibility_to | 1.59717659 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.56733604 |
| 50 | MP0002006_tumorigenesis | 1.55048314 |
| 51 | MP0010307_abnormal_tumor_latency | 1.50635748 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.48997674 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.46217429 |
| 54 | MP0003866_abnormal_defecation | 1.44901670 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.42552513 |
| 56 | MP0001873_stomach_inflammation | 1.40596945 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 1.40542624 |
| 58 | MP0003448_altered_tumor_morphology | 1.35422015 |
| 59 | MP0004510_myositis | 1.33921745 |
| 60 | MP0002933_joint_inflammation | 1.27279778 |
| 61 | MP0000858_altered_metastatic_potential | 1.24539706 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.22558043 |
| 63 | MP0008260_abnormal_autophagy | 1.21105656 |
| 64 | MP0002132_abnormal_respiratory_system | 1.16741768 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.15568907 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.14559631 |
| 67 | MP0008058_abnormal_DNA_repair | 1.13962897 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.12905243 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.10578622 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 1.07305449 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 1.06340019 |
| 72 | MP0005310_abnormal_salivary_gland | 1.05044846 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.02797481 |
| 74 | MP0005023_abnormal_wound_healing | 1.00353895 |
| 75 | MP0000313_abnormal_cell_death | 1.00294527 |
| 76 | MP0008469_abnormal_protein_level | 1.00292518 |
| 77 | MP0003091_abnormal_cell_migration | 0.98873902 |
| 78 | MP0003123_paternal_imprinting | 0.98003169 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 0.95099837 |
| 80 | MP0005409_darkened_coat_color | 0.94205882 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93973135 |
| 82 | MP0009672_abnormal_birth_weight | 0.92727134 |
| 83 | MP0000566_synostosis | 0.92472024 |
| 84 | MP0001730_embryonic_growth_arrest | 0.91573662 |
| 85 | MP0005621_abnormal_cell_physiology | 0.90300568 |
| 86 | MP0009764_decreased_sensitivity_to | 0.89433168 |
| 87 | MP0003828_pulmonary_edema | 0.88861787 |
| 88 | MP0009840_abnormal_foam_cell | 0.88643055 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.88537628 |
| 90 | MP0000609_abnormal_liver_physiology | 0.87920741 |
| 91 | MP0002009_preneoplasia | 0.87697125 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.87598672 |
| 93 | MP0003718_maternal_effect | 0.87030675 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.85162564 |
| 95 | MP0000343_altered_response_to | 0.84677009 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.83808442 |
| 97 | MP0009115_abnormal_fat_cell | 0.81442332 |
| 98 | MP0003984_embryonic_growth_retardation | 0.81345474 |
| 99 | MP0002088_abnormal_embryonic_growth/wei | 0.80743200 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.79800565 |
| 101 | MP0005390_skeleton_phenotype | 0.79193627 |
| 102 | MP0002086_abnormal_extraembryonic_tissu | 0.76598263 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75702777 |
| 104 | MP0005380_embryogenesis_phenotype | 0.74686707 |
| 105 | MP0001672_abnormal_embryogenesis/_devel | 0.74686707 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.71671227 |
| 107 | MP0001915_intracranial_hemorrhage | 0.71633833 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.71197148 |
| 109 | MP0008932_abnormal_embryonic_tissue | 0.71022911 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.70586995 |
| 111 | MP0001697_abnormal_embryo_size | 0.69754024 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.69023672 |
| 113 | MP0001663_abnormal_digestive_system | 0.66774917 |
| 114 | MP0000371_diluted_coat_color | 0.66657996 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.66395132 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.65631419 |
| 117 | MP0004197_abnormal_fetal_growth/weight/ | 0.64822771 |
| 118 | MP0002080_prenatal_lethality | 0.63141860 |
| 119 | MP0001293_anophthalmia | 0.62205149 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.61614190 |
| 121 | MP0006054_spinal_hemorrhage | 0.61475338 |
| 122 | MP0000733_abnormal_muscle_development | 0.60017010 |
| 123 | * MP0000477_abnormal_intestine_morphology | 0.59762788 |
| 124 | MP0001851_eye_inflammation | 0.59699887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.03483211 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.17148801 |
| 3 | Recurrent fungal infections (HP:0002841) | 3.90570424 |
| 4 | Recurrent viral infections (HP:0004429) | 3.73868950 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 3.70059755 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59024781 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.44037751 |
| 8 | Myositis (HP:0100614) | 3.32582609 |
| 9 | Abnormality of the fingertips (HP:0001211) | 3.30349517 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.17603938 |
| 11 | Stomatitis (HP:0010280) | 3.13048146 |
| 12 | Obstructive lung disease (HP:0006536) | 3.01015106 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01015106 |
| 14 | T lymphocytopenia (HP:0005403) | 3.00108295 |
| 15 | Abnormality of T cell number (HP:0011839) | 2.92085171 |
| 16 | Deep venous thrombosis (HP:0002625) | 2.90155600 |
| 17 | Thrombocytosis (HP:0001894) | 2.88582081 |
| 18 | Abnormality of macrophages (HP:0004311) | 2.84811905 |
| 19 | Orchitis (HP:0100796) | 2.78108874 |
| 20 | IgM deficiency (HP:0002850) | 2.76366476 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.72883007 |
| 22 | Optic neuritis (HP:0100653) | 2.72883007 |
| 23 | Abnormality of T cells (HP:0002843) | 2.71545287 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71484439 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71484439 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68774440 |
| 27 | Progressive external ophthalmoplegia (HP:0000590) | 2.66266759 |
| 28 | Asymmetry of the thorax (HP:0001555) | 2.61358047 |
| 29 | Flat acetabular roof (HP:0003180) | 2.58953087 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.55834626 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 2.55665399 |
| 32 | Vasculitis (HP:0002633) | 2.54212193 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.52855963 |
| 34 | Syringomyelia (HP:0003396) | 2.51754521 |
| 35 | Spinal cord lesions (HP:0100561) | 2.51754521 |
| 36 | Cellulitis (HP:0100658) | 2.50115324 |
| 37 | Recurrent skin infections (HP:0001581) | 2.47834904 |
| 38 | Abnormal tarsal ossification (HP:0008369) | 2.46449762 |
| 39 | Combined immunodeficiency (HP:0005387) | 2.46235281 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.43390622 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.42672539 |
| 42 | B lymphocytopenia (HP:0010976) | 2.42672539 |
| 43 | Periodontitis (HP:0000704) | 2.40086602 |
| 44 | Leukocytosis (HP:0001974) | 2.39944059 |
| 45 | Deep palmar crease (HP:0006191) | 2.38412173 |
| 46 | Meningitis (HP:0001287) | 2.38168416 |
| 47 | Short 4th metacarpal (HP:0010044) | 2.37757346 |
| 48 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.37757346 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.35956485 |
| 50 | Gingivitis (HP:0000230) | 2.33875383 |
| 51 | Abnormal foot bone ossification (HP:0010675) | 2.33434713 |
| 52 | Pustule (HP:0200039) | 2.30888432 |
| 53 | Acute myeloid leukemia (HP:0004808) | 2.30356453 |
| 54 | Chronic diarrhea (HP:0002028) | 2.30117663 |
| 55 | Chromsome breakage (HP:0040012) | 2.30064108 |
| 56 | Increased density of long bones (HP:0006392) | 2.29677286 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29600114 |
| 58 | IgA deficiency (HP:0002720) | 2.28516649 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.27805948 |
| 60 | Overlapping toe (HP:0001845) | 2.26698334 |
| 61 | Chronic otitis media (HP:0000389) | 2.25817226 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.25746614 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.24354969 |
| 64 | Lymphopenia (HP:0001888) | 2.24214381 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.22895042 |
| 66 | Leiomyosarcoma (HP:0100243) | 2.22555510 |
| 67 | Uterine leiomyosarcoma (HP:0002891) | 2.22555510 |
| 68 | Petechiae (HP:0000967) | 2.22553962 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.21746184 |
| 70 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.21023762 |
| 71 | Ectopic kidney (HP:0000086) | 2.20999352 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.18979208 |
| 73 | Lymphoma (HP:0002665) | 2.18376261 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18078947 |
| 75 | Eosinophilia (HP:0001880) | 2.18052478 |
| 76 | Chest pain (HP:0100749) | 2.16881678 |
| 77 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.15757640 |
| 78 | Heterotopia (HP:0002282) | 2.14681057 |
| 79 | Hemoptysis (HP:0002105) | 2.11952564 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.09310192 |
| 81 | Arterial thrombosis (HP:0004420) | 2.08282901 |
| 82 | Abnormality of the lumbar spine (HP:0100712) | 2.05281178 |
| 83 | Urethral obstruction (HP:0000796) | 2.03315581 |
| 84 | Osteomyelitis (HP:0002754) | 2.02341589 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.02008567 |
| 86 | Long eyelashes (HP:0000527) | 2.01825746 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.01125383 |
| 88 | Embryonal renal neoplasm (HP:0011794) | 2.01046360 |
| 89 | Myelodysplasia (HP:0002863) | 2.00808335 |
| 90 | Increased IgE level (HP:0003212) | 2.00436415 |
| 91 | Progressive hearing impairment (HP:0001730) | 2.00192009 |
| 92 | Reticulocytopenia (HP:0001896) | 2.00000324 |
| 93 | Progressive muscle weakness (HP:0003323) | 1.99791525 |
| 94 | Thyroiditis (HP:0100646) | 1.99614477 |
| 95 | Metaphyseal cupping (HP:0003021) | 1.98792448 |
| 96 | Abnormality of eosinophils (HP:0001879) | 1.96166368 |
| 97 | Abnormality of the anterior horn cell (HP:0006802) | 1.95640915 |
| 98 | Degeneration of anterior horn cells (HP:0002398) | 1.95640915 |
| 99 | Granulocytopenia (HP:0001913) | 1.95508170 |
| 100 | Amaurosis fugax (HP:0100576) | 1.94897643 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.94003938 |
| 102 | Facial hemangioma (HP:0000329) | 1.92801559 |
| 103 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.92409607 |
| 104 | Urticaria (HP:0001025) | 1.92050335 |
| 105 | Long palpebral fissure (HP:0000637) | 1.90240686 |
| 106 | Increased IgM level (HP:0003496) | 1.89788200 |
| 107 | Hyperacusis (HP:0010780) | 1.89579647 |
| 108 | Broad palm (HP:0001169) | 1.89220248 |
| 109 | Renal cell carcinoma (HP:0005584) | 1.89179506 |
| 110 | Disinhibition (HP:0000734) | 1.88919149 |
| 111 | Volvulus (HP:0002580) | 1.88799627 |
| 112 | Leukopenia (HP:0001882) | 1.87864617 |
| 113 | Agnosia (HP:0010524) | 1.87803332 |
| 114 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.87750875 |
| 115 | Gastrointestinal carcinoma (HP:0002672) | 1.87750875 |
| 116 | Trigonocephaly (HP:0000243) | 1.86756901 |
| 117 | Cutis marmorata (HP:0000965) | 1.85314232 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.84472616 |
| 119 | Encephalitis (HP:0002383) | 1.83470259 |
| 120 | Deep philtrum (HP:0002002) | 1.83253371 |
| 121 | Septate vagina (HP:0001153) | 1.83241766 |
| 122 | IgG deficiency (HP:0004315) | 1.83004168 |
| 123 | Acute lymphatic leukemia (HP:0006721) | 1.82024560 |
| 124 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81869076 |
| 125 | Abnormality of chromosome stability (HP:0003220) | 1.80908434 |
| 126 | Abnormality of the pleura (HP:0002103) | 1.79829006 |
| 127 | Anal stenosis (HP:0002025) | 1.79110245 |
| 128 | Progressive sensorineural hearing impairment (HP:0000408) | 1.76338753 |
| 129 | Deviation of the thumb (HP:0009603) | 1.75701109 |
| 130 | Aplastic anemia (HP:0001915) | 1.75639880 |
| 131 | Bicuspid aortic valve (HP:0001647) | 1.75535995 |
| 132 | Porencephaly (HP:0002132) | 1.74851739 |
| 133 | Impulsivity (HP:0100710) | 1.74606042 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74026460 |
| 135 | Gastrointestinal infarctions (HP:0005244) | 1.73906151 |
| 136 | Skin ulcer (HP:0200042) | 1.73419323 |
| 137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72743363 |
| 138 | Proximal placement of thumb (HP:0009623) | 1.72089517 |
| 139 | Increased nuchal translucency (HP:0010880) | 1.72070542 |
| 140 | Abnormality of the thoracic spine (HP:0100711) | 1.71272968 |
| 141 | Delayed epiphyseal ossification (HP:0002663) | 1.71162389 |
| 142 | Abnormality of the peritoneum (HP:0002585) | 1.70787099 |
| 143 | Fatigue (HP:0012378) | 1.70569897 |
| 144 | Bladder carcinoma (HP:0002862) | 1.69789587 |
| 145 | Bladder neoplasm (HP:0009725) | 1.69789587 |
| 146 | Abnormal number of incisors (HP:0011064) | 1.69399298 |
| 147 | Somatic mutation (HP:0001428) | 1.69315023 |
| 148 | Keratoconjunctivitis (HP:0001096) | 1.69009354 |
| 149 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68767290 |
| 150 | Keratoconjunctivitis sicca (HP:0001097) | 1.68018804 |
| 151 | Dislocated radial head (HP:0003083) | 1.67746977 |
| 152 | Thin bony cortex (HP:0002753) | 1.67376629 |
| 153 | Intestinal fistula (HP:0100819) | 1.66886813 |
| 154 | 11 pairs of ribs (HP:0000878) | 1.66722643 |
| 155 | Prominent nose (HP:0000448) | 1.66038841 |
| 156 | Limited elbow extension (HP:0001377) | 1.65923304 |
| 157 | Supernumerary ribs (HP:0005815) | 1.65881870 |
| 158 | Premature ovarian failure (HP:0008209) | 1.63951888 |
| 159 | Aseptic necrosis (HP:0010885) | 1.62493108 |
| 160 | Viral hepatitis (HP:0006562) | 1.61642793 |
| 161 | Prolonged bleeding time (HP:0003010) | 1.61096005 |
| 162 | Gangrene (HP:0100758) | 1.60781018 |
| 163 | Metaphyseal irregularity (HP:0003025) | 1.60290904 |
| 164 | Multiple enchondromatosis (HP:0005701) | 1.60202293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.85279740 |
| 2 | MAP3K10 | 3.48108644 |
| 3 | PRPF4B | 3.18314930 |
| 4 | SMG1 | 2.90002983 |
| 5 | TXK | 2.88310809 |
| 6 | JAK3 | 2.71927758 |
| 7 | CDK12 | 2.55995331 |
| 8 | MAP3K14 | 2.18286723 |
| 9 | TYK2 | 2.17931564 |
| 10 | IRAK4 | 2.11702518 |
| 11 | CDC7 | 2.10012641 |
| 12 | STK10 | 2.07037391 |
| 13 | ZAP70 | 1.99584892 |
| 14 | BLK | 1.93245562 |
| 15 | TBK1 | 1.92432466 |
| 16 | RPS6KA4 | 1.87059347 |
| 17 | MAP3K13 | 1.83614374 |
| 18 | EEF2K | 1.81885765 |
| 19 | BTK | 1.77797273 |
| 20 | ERN1 | 1.69472951 |
| 21 | NEK2 | 1.68481004 |
| 22 | IKBKE | 1.67364711 |
| 23 | SIK3 | 1.58732053 |
| 24 | CHUK | 1.56016936 |
| 25 | IKBKB | 1.45348960 |
| 26 | TAOK2 | 1.43885163 |
| 27 | KSR2 | 1.42214588 |
| 28 | TEC | 1.38642398 |
| 29 | BRD4 | 1.35177992 |
| 30 | ITK | 1.33067127 |
| 31 | TAOK1 | 1.29045534 |
| 32 | STK24 | 1.26958405 |
| 33 | FGFR4 | 1.25616777 |
| 34 | CLK1 | 1.25198467 |
| 35 | KIT | 1.24498232 |
| 36 | MAP3K9 | 1.21265111 |
| 37 | STK4 | 1.18422384 |
| 38 | TRIB3 | 1.18251456 |
| 39 | SYK | 1.17116486 |
| 40 | CDK4 | 1.16335464 |
| 41 | PIM1 | 1.13752483 |
| 42 | SIK1 | 1.13182286 |
| 43 | FGFR3 | 1.12703587 |
| 44 | LCK | 1.10976838 |
| 45 | LRRK2 | 1.10006411 |
| 46 | JAK1 | 1.09334033 |
| 47 | HCK | 1.08997335 |
| 48 | ATR | 1.08976613 |
| 49 | PKN2 | 1.08775468 |
| 50 | CDK6 | 1.06710672 |
| 51 | TYRO3 | 1.04983659 |
| 52 | MATK | 1.03782886 |
| 53 | TGFBR1 | 1.03437032 |
| 54 | PIM2 | 1.03009297 |
| 55 | MKNK1 | 1.01286112 |
| 56 | MAP3K1 | 1.00641660 |
| 57 | CSK | 0.98473852 |
| 58 | FGR | 0.97860863 |
| 59 | IRAK3 | 0.96638326 |
| 60 | PLK4 | 0.95793955 |
| 61 | MAPK11 | 0.93889492 |
| 62 | TTK | 0.93695886 |
| 63 | RIPK1 | 0.92855278 |
| 64 | STK3 | 0.92758682 |
| 65 | CSF1R | 0.92744210 |
| 66 | MAP3K8 | 0.91344846 |
| 67 | IRAK2 | 0.89168047 |
| 68 | WNK1 | 0.88781338 |
| 69 | PBK | 0.87891449 |
| 70 | BUB1 | 0.87780879 |
| 71 | LYN | 0.87692236 |
| 72 | MAP2K3 | 0.85780368 |
| 73 | EPHA3 | 0.84726114 |
| 74 | EPHB1 | 0.83578903 |
| 75 | PTK6 | 0.83251032 |
| 76 | MELK | 0.83032642 |
| 77 | CDC42BPA | 0.81583129 |
| 78 | TGFBR2 | 0.79821019 |
| 79 | MAP3K3 | 0.78887339 |
| 80 | RIPK4 | 0.78229086 |
| 81 | NME2 | 0.78112842 |
| 82 | NLK | 0.77208084 |
| 83 | JAK2 | 0.76204978 |
| 84 | YES1 | 0.73904240 |
| 85 | ALK | 0.73567833 |
| 86 | AURKB | 0.71747867 |
| 87 | MAPKAPK2 | 0.70848274 |
| 88 | DYRK3 | 0.70184343 |
| 89 | MARK3 | 0.70044264 |
| 90 | MAP3K11 | 0.69158796 |
| 91 | CDK7 | 0.68968800 |
| 92 | PASK | 0.68803374 |
| 93 | CDK9 | 0.65742774 |
| 94 | TSSK6 | 0.64880501 |
| 95 | SIK2 | 0.62961518 |
| 96 | BRAF | 0.62561527 |
| 97 | CHEK1 | 0.61876785 |
| 98 | TAF1 | 0.60549610 |
| 99 | MTOR | 0.59774238 |
| 100 | NEK9 | 0.59311041 |
| 101 | BRSK2 | 0.58388060 |
| 102 | PAK4 | 0.58088997 |
| 103 | SRPK1 | 0.56705458 |
| 104 | TESK2 | 0.55795686 |
| 105 | KDR | 0.54838555 |
| 106 | ERBB3 | 0.54777903 |
| 107 | WEE1 | 0.54511428 |
| 108 | DMPK | 0.54493578 |
| 109 | CAMK1D | 0.54122178 |
| 110 | MARK2 | 0.53674464 |
| 111 | PDGFRA | 0.51576536 |
| 112 | ACVR1B | 0.51074862 |
| 113 | TAOK3 | 0.50590672 |
| 114 | ATM | 0.50451356 |
| 115 | EIF2AK1 | 0.50230090 |
| 116 | CHEK2 | 0.49040978 |
| 117 | HIPK2 | 0.48856651 |
| 118 | EGFR | 0.48832487 |
| 119 | CAMK1G | 0.48764023 |
| 120 | MAP3K5 | 0.48141067 |
| 121 | CDK8 | 0.47576414 |
| 122 | PLK1 | 0.46920781 |
| 123 | FGFR1 | 0.46830904 |
| 124 | SGK3 | 0.45665371 |
| 125 | PDPK1 | 0.44807143 |
| 126 | KSR1 | 0.44025179 |
| 127 | ARAF | 0.43963294 |
| 128 | ICK | 0.43627651 |
| 129 | PDK1 | 0.42325443 |
| 130 | GRK6 | 0.40757548 |
| 131 | CDK2 | 0.40470400 |
| 132 | RPS6KA1 | 0.40361573 |
| 133 | DDR2 | 0.40217654 |
| 134 | IRAK1 | 0.39765447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53130471 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43860372 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.35556498 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.16212333 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15041818 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.99405972 |
| 7 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.90847627 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81986526 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81953284 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81001803 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.80337868 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.78291685 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75026070 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70078045 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.69453723 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67219432 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65688691 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64427224 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.62969829 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62234506 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59631490 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.58585439 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54873974 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52460938 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50238708 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.49299185 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48783500 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.48207620 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45229953 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.42996311 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42675034 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42626703 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.41300441 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.38458917 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.28251264 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.27255459 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.26683438 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.22833728 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22299184 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.22282057 |
| 41 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22011665 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.21224639 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20772295 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20387561 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.17979317 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16425700 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.16099157 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15356345 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13713362 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10645329 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09841908 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.08963763 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07070997 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06775996 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06341197 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.05423731 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05091064 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00607434 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.99437265 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98799406 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98071317 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96597626 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96498379 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96050718 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95576072 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92708306 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92497205 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92021414 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.90844615 |
| 70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88850046 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.86425499 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85773841 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.84197798 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82454394 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81341727 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.81314073 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78958944 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78192863 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77645303 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71914475 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71905540 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69316963 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68525973 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66956576 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66807202 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65674074 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65566578 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64662028 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62644147 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61656250 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.59820350 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57254399 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.57189348 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57137934 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.54830020 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54487317 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.53683617 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53145684 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.52690725 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51910148 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51273894 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50542048 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50064528 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49200133 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48963557 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48876934 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48225890 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.46103675 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45709523 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45461494 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45086952 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43984158 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42228093 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41077806 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37515337 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.36944439 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35999793 |

